

A provider's guide to helping patients save on Orapred. Learn about generics, coupon cards, patient assistance programs, and cost-effective alternatives.
As a prescriber, you know that Orapred (Prednisolone Sodium Phosphate) is a go-to corticosteroid for pediatric patients with asthma exacerbations, croup, allergic conditions, and autoimmune disorders. What you may not always see is the financial impact on the other side of the prescription pad.
Brand-name Orapred oral solution can cost $50–$200+ out of pocket. Orapred ODT runs $200–$500+ without insurance. For families managing recurrent conditions that require multiple courses per year, these costs add up quickly — and can lead to non-adherence, dose-skipping, or patients simply not filling the prescription at all.
This guide provides actionable strategies you can share with patients (and implement in your practice) to reduce the financial burden of Orapred prescriptions.
The single most impactful cost-saving step is prescribing generic Prednisolone Sodium Phosphate instead of brand-name Orapred.
Generic Prednisolone Sodium Phosphate is bioequivalent to brand-name Orapred and is rated as a Tier 1 preferred generic on most insurance formularies. Unless there's a specific clinical reason for the brand (e.g., documented intolerance to a generic formulation's inactive ingredients), the generic should be the default.
Practice tip: Write prescriptions for "Prednisolone Sodium Phosphate oral solution" rather than "Orapred" to ensure the pharmacy dispenses the generic automatically.
For uninsured or underinsured patients, prescription discount cards can significantly reduce out-of-pocket costs. These are free, no-enrollment programs that negotiate lower prices at participating pharmacies.
Recommended resources to share with patients:
These cards can bring the cost of generic Prednisolone oral solution down to $10–$25 in many cases. They cannot be combined with insurance, but for patients with high deductibles or no coverage for the brand, they often beat the insurance price.
For a comprehensive list of savings options, refer patients to our guide: How to Save Money on Orapred.
For patients with financial hardship — especially those who are uninsured or on fixed incomes — patient assistance programs (PAPs) can provide medications at no cost or reduced cost.
Concordia Pharmaceuticals (the manufacturer of Orapred) has not maintained an active patient savings or copay card program in recent years. This makes generic substitution and third-party programs even more important for Orapred specifically.
Consider training a staff member (often a medical assistant or social worker) to help patients navigate these programs. The application process can be daunting for patients, and a little guidance goes a long way. Some EHR systems can flag patients who may qualify for assistance based on insurance status and demographics.
When Orapred is prescribed for its liquid formulation (usually for pediatric patients), it's worth knowing the cost landscape of therapeutic alternatives:
Generic Prednisone is one of the least expensive medications on the market — often $5 or less for a short course. For older children who can tolerate crushed tablets mixed with food or a spoonful of pudding/applesauce, this can be a viable and significantly cheaper alternative.
Caveat: Not suitable for very young children or patients who cannot tolerate the bitter taste. Prednisone also requires hepatic conversion to Prednisolone, making it less ideal for patients with liver dysfunction.
Dexamethasone is available as a liquid and is more potent than Prednisolone (0.75 mg Dexamethasone ≈ 5 mg Prednisolone). For croup, a single dose of Dexamethasone (0.6 mg/kg) is an evidence-based alternative to a multi-day Prednisolone course. Generic Dexamethasone solution is often $10–$30.
For adult patients, the Medrol Dosepak provides a pre-packaged tapering course. Generic Methylprednisolone tablets are typically $10–$25. Not available in liquid form, so not ideal for pediatric patients.
For a clinical comparison of alternatives, see our provider-focused guide on the Orapred shortage and our patient-facing article on alternatives to Orapred.
Cost savings don't matter if the patient can't find the medication. Orapred and Prednisolone oral solutions have faced intermittent shortages, and provider awareness is critical.
MedFinder for Providers helps you and your staff identify which pharmacies currently have Prednisolone in stock. You can direct patients to specific pharmacies or send e-prescriptions to locations with confirmed availability.
For a comprehensive provider guide on managing the shortage, see How to Help Your Patients Find Orapred in Stock.
Help patients get the most from their existing insurance coverage:
Consider integrating cost awareness into your prescribing workflow:
| Medication | Form | Typical Cash Price | With Coupon/Generic |
|---|---|---|---|
| Orapred (brand) | Oral solution 15 mg/5 mL | $50–$200+ | N/A (no manufacturer coupon) |
| Orapred ODT (brand) | Orally disintegrating tablet | $200–$500+ | N/A |
| Generic Prednisolone solution | Oral solution 15 mg/5 mL | $15–$50 | $10–$25 with coupon |
| Generic Prednisone tablets | Tablets | $5–$20 | $3–$10 with coupon |
| Generic Dexamethasone solution | Oral solution | $10–$30 | $8–$20 with coupon |
Medication cost is a barrier to adherence, and as a provider, you're in a unique position to help patients overcome it. For Orapred specifically, the most impactful steps are:
Small efforts in your prescribing workflow can make a significant difference in whether your patients can afford to fill and complete their corticosteroid courses.
You focus on staying healthy. We'll handle the rest.
Try Medfinder Concierge FreeMedfinder's mission is to ensure every patient gets access to the medications they need. We believe this begins with trustworthy information. Our core values guide everything we do, including the standards that shape the accuracy, transparency, and quality of our content. We’re committed to delivering information that’s evidence-based, regularly updated, and easy to understand. For more details on our editorial process, see here.